ClinicalTrials.Veeva

Menu

Early Postoperative Day 0 Chest Tube Removal After Thoracoscopic Minor Surgeries (CTremoval)

I

Insel Gruppe AG, University Hospital Bern

Status

Enrolling

Conditions

Lung Pathologies of Unclear Etiology

Treatments

Procedure: Chest tube removal according to traditional standard protocol not earlier than on postoperative day 1 (POD 1).
Procedure: Early postoperative day 0 (POD 0) chest tube removal.

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The safe conditions for early chest tube removal have been progressively questioned and redefined around reliable digital air flow criteria and extension of liquid threshold accepted. Nevertheless, in current practice, the chest tube remains in restricting early mobilization and optimal compliance with ERAS programme, during the first crucial 24 h after surgery. Thus, to go further, the investigators decide to assess in this study the safety of POD 0 chest tube removal after minor thoracic operations in patients in health condition tolerating operation and anesthesia.

Full description

Chest tube management is a key element of postoperative care after thoracic surgeries for different indications. During the last decade, minimally invasive surgery and enhanced recovery after surgery (ERAS) programmes have radically changed the equation of recovery, contributing to reduce postoperative morbidity and enhance quality of life, but the chest tube remains its Achilles heel, still providing postoperative pain and impairing pulmonary function. In this view, early chest tube removal has been widely promoted not only for its economic benefits on length of stay but also for improving quality of life and potentially reducing postoperative complications. In parallel, the change from traditional chest drainage devices to electronic devices has also enabled a more accurate air leak measurement with reduction of interobserver variability, decreased chest drainage duration and shortened LOS. The safe conditions for early chest tube removal have been progressively questioned and redefined around reliable digital air flow criteria and extension of liquid threshold accepted. Nevertheless, in current practice, the chest tube remains in restricting early mobilization and optimal compliance with ERAS programme, during the first crucial 24 h after surgery. Thus, to go further, the investigators decide to assess in this study the safety of POD 0 chest tube removal after minor thoracic operations in patients in health condition tolerating operation and anesthesia.

Enrollment

304 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Thoracoscopic extra-anatomical lung resection (surgical lung biopsy)
  2. Thoracoscopic pleural biopsy
  3. Signed consent
  4. Age of majority

Exclusion criteria

  1. Anatomical resection
  2. Empyema
  3. Pleural effusion
  4. Pleurodesis
  5. Vulnerable persons (Pregnant women, Children and adolescents)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

304 participants in 2 patient groups

Test group
Other group
Description:
Test group: The patients of the study group are getting their chest tube removed according to the investigators' current airleak protocol (Flow \<20 mL/ min on digital suction device) but already in the operating room immediately following wound closure (Postoperative day 0 (POD0)). If airleak is persisting than chest tube removal will be performed according to the traditional protocol not earlier than on postoperative day 1 (POD 1).
Treatment:
Procedure: Early postoperative day 0 (POD 0) chest tube removal.
Control group
Other group
Description:
In the control group, the chest tube gets removed according to the investigators' traditional standard protocol not earlier than on postoperative day 1 (POD1).
Treatment:
Procedure: Chest tube removal according to traditional standard protocol not earlier than on postoperative day 1 (POD 1).

Trial contacts and locations

1

Loading...

Central trial contact

Patrick Dorn, PD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems